ICH E6(R3) Principles

Trace the evolution of research ethics from the Nuremberg Code through the Declaration of Helsinki and Belmont Report to understand why GCP protections exist.

Navigate the international framework of clinical trial regulation, from ICH harmonization to regional requirements across FDA, EMA, PMDA, and NMPA jurisdictions.

Master the organization of ICH E6(R3) to locate guidance efficiently: the Principles section, Annex 1 operational requirements, Appendices, and Glossary.

Understand ICH E6(R3) Principle 1 and its six sub-principles that establish participant rights, safety, and well-being as the foundation of all clinical trial conduct.

Understand informed consent as an ethical cornerstone requiring voluntary, informed decision-making, including requirements for legally acceptable representatives and assent.

Understand the requirement for independent ethical review by an IRB/IEC, including prior approval, continuing review, composition requirements, and procedural safeguards.

Understand the requirement that clinical trials be based on adequate nonclinical and clinical information, reflect current scientific knowledge, and undergo periodic review as new information emerges.

Learn how ICH E6(R3) requires proportionate approaches that scale trial oversight and activities to the actual risks and importance of the data collected, focusing resources where they matter most.

Learn how ICH E6(R3) establishes the systems, processes, and documentation requirements that ensure trial results are reliable enough to support regulatory decisions and clinical practice.

Learn how ICH E6(R3) requires clear documentation of roles and responsibilities, establishing accountability frameworks that prevent gaps and overlaps while enabling appropriate delegation with maintained oversight.

Learn the specific regulatory requirements for investigator qualifications, product familiarity, and resource documentation that must be established before a clinical trial begins at any site.

Learn how investigators can delegate trial activities to qualified staff while retaining responsibility, implementing proportionate oversight, and maintaining documentation that enables monitoring, audit, and inspection.

Master the investigator's dual obligation to provide qualified medical care during trial participation and to report adverse events accurately according to protocol-specified timelines.

Master the comprehensive requirements for obtaining, documenting, and maintaining informed consent, including required document elements, re-consent procedures, and consent for participants who cannot consent themselves.

Master the fundamental requirements for maintaining accurate, complete, and legible trial records, distinguishing source documents from derived data, and applying ALCOA+ principles to all documentation.

Master the investigator's reporting obligations throughout the trial lifecycle, including progress reports, safety reports, and final reports to both the IRB/IEC and sponsor.